Stay updated on Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer now displays site revision v3.7.2 instead of v3.7.1. The study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-14T17:33:54.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-07T18:08:44.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the usual study content and indicating restricted access to the record.
    Difference
    21%
    Check dated 2026-09-23T21:43:27.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.6.6 to v3.7.0, indicating a new version of the page content.
    Difference
    0.0%
    Check dated 2026-09-16T22:19:47.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing the previous v3.6.5, indicating a minor administrative update to the study record.
    Difference
    0.0%
    Check dated 2026-09-02T20:01:35.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Added access to the Study Protocol and Statistical Analysis Plan PDFs in the Study Documents section, along with associated metadata such as file size and upload dates.
    Difference
    72%
    Check dated 2026-08-12T02:51:49.000Z thumbnail image

Stay in the know with updates to Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page.